Savient Pharmaceuticals Inc's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Savient Pharmaceuticals Inc in the third quarter 2013?
Due to the lack of equity, it was not possible to calculate Savient Pharmaceuticals Inc's return on equity (ROE) in its third quarter 2013

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Sep 30 2013) III. Quarter	(Jun 30 2013) II. Quarter	(Mar 31 2013) I. Quarter	(Dec 31 2012) IV. Quarter	(Sep 30 2012) III. Quarter
Y / Y Equity Change	-	-	-	-	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in Millions	-98	-118	-109	-118	-90
Return On Equity (TTM)	-	-	-	-	-
SVNT's Total Ranking	#	#	#	#	#
Equity (TTM) in Millions	-206	-187	-162	-138	-112
Seq. Equity Change	-	-	-	-	-
Seq. Net Income Change	-	-	-	-	-

Back to SVNT Management Effectiveness >> SVNT's 5 Years Annual ROE >> Compare SVNT ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Equity Statistics
High	Average	Low
0 %	0 %	0 %

SVNT Annual Return On Equity	(Dec 31 2012) 2012	(Dec 31 2011) 2011	(Dec 31 2008) 2010
Total Equity in Millions	-138	-8	64	0	0
Y / Y Equity Change	-	-	-	-	-
Net Income in Millions	-118	-102	-84	0	0
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	-	-	-131.11 %	-	-

Back to SVNT Management Effectiveness >> SVNT's 5 Years Annual ROE >> Compare SVNT ROE to its Competitors

More Return On Equity Ratios
Biotechnology & Pharmaceuticals Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
SVNT's' Return on Equity at Yahoo Finance
SVNT's Roe Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for SVNT's Competitors
Subscribers only: Roe for Savient Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Equity for SVNT's Customers

Companies with similar Return On Equity at Sep 30 2013, within Healthcare Sector	ROE
Brainstorm Cell Therapeutics inc	118.72 %
Encompass Health Corporation	102.99 %
Oramed Pharmaceuticals Inc	79.41 %
China Yct International Group, Inc.	75.14 %
Fonar Corporation	69.71 %
Regeneron Pharmaceuticals Inc	54.70 %
Pacific Health Care Organization Inc	53.37 %
Veru Inc	53.00 %
Camp4 Therapeutics Corporation	41.48 %
Mettler toledo International Inc	36.59 %
Acorda Therapeutics Inc	35.61 %
Cambrex Corp	34.75 %
Pfizer Inc	32.18 %
China Biologic Products Holdings Inc	32.18 %
Idexx Laboratories Inc	31.96 %
Waters Corporation	31.85 %
Sunlink Health Systems Inc	31.00 %
Eli Lilly And Company	30.94 %
Jazz Pharmaceuticals Plc	30.76 %
Cellular Biomedicine Group Inc	30.45 %
Baxter International Inc	30.14 %
Ligand Pharmaceuticals Incorporated	30.08 %
Gilead Sciences Inc	28.53 %
Psychemedics Corporation	27.72 %
Varian Medical Systems Inc	27.09 %
Edwards Lifesciences Corporation	26.74 %
Arena Pharmaceuticals Inc	26.70 %
Celgene Corp	26.58 %
United Therapeutics Corporation	25.66 %
Meridian Bioscience Inc	25.66 %

Date modified: 2026-09-02T17:38:16+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.